Seller: KCMidwestbooks, Leawood, KS, U.S.A.
Hardcover. Condition: New. Book is n new condition. Pages are clean, crisp, free from markings and unread.
Condition: New.
Condition: As New. Unread book in perfect condition.
US$ 92.35
Quantity: 1 available
Add to basketCondition: New.
Seller: Phatpocket Limited, Waltham Abbey, HERTS, United Kingdom
US$ 103.63
Quantity: 1 available
Add to basketCondition: Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.
Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
US$ 106.63
Quantity: 1 available
Add to basketCondition: As New. Unread book in perfect condition.
Condition: Sehr gut. Zustand: Sehr gut | Seiten: 448 | Sprache: Englisch | Produktart: Bücher | Neuroscience's inherent complexity and rapid growth mean that no one can keep abreast of all the changes across the field. We each bring a necessarily narrow perspective. Neurotherapeutics: Emerg ing Strategies is an attempt to provide some diverse perspectives within the hunt for new drugs to treat central nervous system diseases. The book's premise is that the search for new drugs is based on an understanding ofboth clinical and basic sciences. Neurotherapeu tics: Emerging Strategies begins with psychiatry and concludes with neurological disorders. Each chapter examines a disease, including clinical features and existing treatments, but the emphasis is on current concepts of underlying causes and novel strategies for drug discovery arising from these possible mechanisms. Participating authors include basic neuroscientists, industry-based pharmacolo gists and chemists, and clinicians. The chapters describe the status of the existing disease treat ments, and when treatments are lacking, the approach is more basic science oriented. When there is a long history of treatment, there is greater emphasis on those therapies. However, all the chapters seem to reflect the benefits of cloning, since the availability of receptor subtypes now promises the opportunity for greater specificity of drug effects. Modulation of second messengers is another new and recur ring theme. And in the chapter on cachexia, cytokines are explored both as drugs and drug targets. Neurotherapeutics: Emerging Strategies reflects the complex ity of the nervous system, but the overriding message is hope for new and better drugs to treat those diseases that rob us of ourselves.
Condition: Used. pp. 448.
US$ 161.39
Quantity: 1 available
Add to basketCondition: Used. pp. 448 9:B&W 6 x 9 in or 229 x 152 mm Case Laminate on Creme w/Gloss Lam.
Condition: Used. pp. 448.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
US$ 191.41
Quantity: Over 20 available
Add to basketCondition: New. In.
US$ 163.27
Quantity: Over 20 available
Add to basketCondition: New.
US$ 163.27
Quantity: Over 20 available
Add to basketGebunden. Condition: New.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
US$ 220.99
Quantity: Over 20 available
Add to basketCondition: New. In.
Condition: New. Series: Contemporary Neuroscience. Num Pages: 434 pages, biography. BIC Classification: MMG. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 23. Weight in Grams: 652. . 2013. Softcover reprint of the original 1st ed. 1996. Paperback. . . . .
Condition: New. pp. 448.
Condition: New. This text aims to assist basic neuroscientists, industry-based pharmacologists, and chemists and clinicians in developing new and better drugs to treat neurological diseases. Each chapter examines a neurological disease, including clinical features and existing treatments. Series: Contemporary Neuroscience. Num Pages: 434 pages, biography. BIC Classification: MJN; MMG; PSAN. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 227 x 152 x 28. Weight in Grams: 825. . 1995. Hardback. . . . .
US$ 274.19
Quantity: 2 available
Add to basketPaperback. Condition: Brand New. 444 pages. 9.02x5.98x1.06 inches. In Stock.
Condition: New. Series: Contemporary Neuroscience. Num Pages: 434 pages, biography. BIC Classification: MMG. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 23. Weight in Grams: 652. . 2013. Softcover reprint of the original 1st ed. 1996. Paperback. . . . . Books ship from the US and Ireland.
Condition: New. This text aims to assist basic neuroscientists, industry-based pharmacologists, and chemists and clinicians in developing new and better drugs to treat neurological diseases. Each chapter examines a neurological disease, including clinical features and existing treatments. Series: Contemporary Neuroscience. Num Pages: 434 pages, biography. BIC Classification: MJN; MMG; PSAN. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 227 x 152 x 28. Weight in Grams: 825. . 1995. Hardback. . . . . Books ship from the US and Ireland.
Seller: Brook Bookstore On Demand, Napoli, NA, Italy
Condition: new. Questo è un articolo print on demand.
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Neuroscience's inherent complexity and rapid growth mean that no one can keep abreast of all the changes across the field. We each bring a necessarily narrow perspective. Neurotherapeutics: Emerg ing Strategies is an attempt to provide some diverse perspectives within the hunt for new drugs to treat central nervous system diseases. The book's premise is that the search for new drugs is based on an understanding ofboth clinical and basic sciences. Neurotherapeu tics: Emerging Strategies begins with psychiatry and concludes with neurological disorders. Each chapter examines a disease, including clinical features and existing treatments, but the emphasis is on current concepts of underlying causes and novel strategies for drug discovery arising from these possible mechanisms. Participating authors include basic neuroscientists, industry-based pharmacolo gists and chemists, and clinicians. The chapters describe the status of the existing disease treat ments, and when treatments are lacking, the approach is more basic science oriented. When there is a long history of treatment, there is greater emphasis on those therapies. However, all the chapters seem to reflect the benefits of cloning, since the availability of receptor subtypes now promises the opportunity for greater specificity of drug effects. Modulation of second messengers is another new and recur ring theme. And in the chapter on cachexia, cytokines are explored both as drugs and drug targets. Neurotherapeutics: Emerging Strategies reflects the complex ity of the nervous system, but the overriding message is hope for new and better drugs to treat those diseases that rob us of ourselves. 448 pp. Englisch.
Seller: Majestic Books, Hounslow, United Kingdom
US$ 248.95
Quantity: 4 available
Add to basketCondition: New. Print on Demand pp. 448.
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Neuroscience's inherent complexity and rapid growth mean that no one can keep abreast of all the changes across the field. We each bring a necessarily narrow perspective. Neurotherapeutics: Emerg ing Strategies is an attempt to provide some diverse perspectives within the hunt for new drugs to treat central nervous system diseases. The book's premise is that the search for new drugs is based on an understanding ofboth clinical and basic sciences. Neurotherapeu tics: Emerging Strategies begins with psychiatry and concludes with neurological disorders. Each chapter examines a disease, including clinical features and existing treatments, but the emphasis is on current concepts of underlying causes and novel strategies for drug discovery arising from these possible mechanisms. Participating authors include basic neuroscientists, industry-based pharmacolo gists and chemists, and clinicians. The chapters describe the status of the existing disease treat ments, and when treatments are lacking, the approach is more basic science oriented. When there is a long history of treatment, there is greater emphasis on those therapies. However, all the chapters seem to reflect the benefits of cloning, since the availability of receptor subtypes now promises the opportunity for greater specificity of drug effects. Modulation of second messengers is another new and recur ring theme. And in the chapter on cachexia, cytokines are explored both as drugs and drug targets. Neurotherapeutics: Emerging Strategies reflects the complex ity of the nervous system, but the overriding message is hope for new and better drugs to treat those diseases that rob us of ourselves.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 448 pp. Englisch.
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. PRINT ON DEMAND pp. 448.